Azathioprine and Allopurinol: How to Avoid Toxic Metabolite Buildup in IBD Treatment
LDAA therapy combines low-dose azathioprine with allopurinol to redirect metabolism away from toxic liver-damaging metabolites toward therapeutic compounds. It’s a proven strategy for IBD patients who can’t tolerate standard azathioprine.
Read More